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Purpose. To evaluate the clinical performance of a silicone hydrogel (Si-Hy) soft contact lens (CL) in combination with three
differentmultipurpose disinfecting solutions (MPDSs).Methods.Thiswas a prospective, randomized, single-masked, crossover, and
comparative study in which 31 habitual soft CL wearers were randomly assigned to one of the three MPDSs (Synergi, COMPLETE
RevitaLens, and OPTI-FREE PureMoist) for 1 month with a 1-week wash-out period between each exposure. All subjects were
successfully refitted with a Si-Hy CL (Biofinity). Subjects were then scheduled for follow-up visits after 1 month of lens wear, being
evaluated at 2 and 8 hours after lens insertion. Visual Analogue Scales (VAS) were used to gauge comfort rating. Results. The tarsal
conjunctiva showed a significantly different degree of lid redness between the MPDSs at the 2-hour visit (𝑃 < 0.05, Kruskal-
Wallis test), being lower for COMPLETE RevitaLens compared to the other two MPDSs (Mann-Whitney 𝑈 test). Furthermore, a
significantly different degree of lid roughness at the 8-hour visit was seen (𝑃 < 0.05, Kruskal-Wallis test), being higher for Synergi
(Mann-Whitney𝑈 test).The subjective comfort was similar with the threeMPDSs.Conclusion.Tarsal conjunctival response should
be also considered in the context of the clinical performance of MPDs at the ocular surface.
1. Introduction
Soft contact lens (CL) wearers frequently report symptoms
of discomfort and dryness [1–3]. Despite that, soft CLs
continue accounting for about 90 percent of all CLs fitted
and silicone hydrogel (Si-Hy) CL in daily wear basis is the
modality of CLs most common fitted [4]. Although soft CLs
have changed significantly during the last years with the
introduction of new materials, designs, and care systems,
discomfort continues being the most frequent reason for CL
wear discontinuation [5–8]. The precise etiology of these
symptoms is unknown, but it is clear that it is multifactorial.
The comfort depends, among other things, on several factors
related to the CLs, but also it is related to the tear quality of
the CL wearers and with lens care regimen used [9–11].
It has been suggested that a lower dehydration rate of CLs
might be an important factor to reduce dryness symptoms
[12]. Gonza´lez-Me´ijome et al. have seen that worn Si-Hy
CLs have lower ability to retain bulk hydration compared
to unworn Si-Hy CLs [13]. In this regard, avoiding on-
eye dehydration of soft CLs is one of the challenges for
ophthalmic materials scientists and CLs industry. Moreover,
a more stable tear film at the lens surface will contribute
positively to the optical quality of the eye [14, 15], thus
potentially reducing patient symptoms.
Nowadays, the CLs care industry is committed to develop
more effective care systems in the form of multipurpose
disinfecting solutions (MPDSs) that attempt to improve the
safety and efficacy of soft CLs. Their results are good from
the antimicrobial and clinical performance perspectives [16–
18]. In fact, The MPDSs are commonly used due to their
simplicity and cost effectiveness, enhancing the compliance
[19]. Nevertheless, after soaking the CLs in the MPDSs
during the night, the liquid remains present in the CLs.
So, when the CLs are placed on the eyes, the liquid is
released in amounts that are dependent on the CL material
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Table 1: Inclusion and exclusion criteria of the present study.
Inclusion criteria Exclusion criteria
18 to 35 years of age
Absence of ocular disease including dry eye
Absence of dry eye symptoms
Flat keratometry between 7.60 and 8.10mm
Refractive sphere between −1.00 and −6.00D
Able to understand and sign Consent Form and attend scheduled
visits
Successful soft contact lens wearers for at least 6 months
Not able to attend visits
Symptomatic contact lens wearer
Known intolerance to MPDS solutions
Dry eye symptoms or signs in the ocular surface (Schirmer
<5mm/5 minutes with closed eyes, corneal or conjunctival
staining >grade II in CCLRU grading scales)
Taking topical or systemic medication
Astigmatism above −0.75D
Other clinically significant ocular findings compatible with
inflammation or any other eye condition
chemistry [20–22]. In this regard, asymptomatic low-grade
punctate corneal staining associated with toxicity of CLs
care solutions is common [23–26]. It has been seen that the
toxic staining is most likely to be observed within 2–4 hours
after inserting the CL [27]. This kind of staining tends to be
extensive but superficial and transient so, in most cases, it is
clinically insignificant and does not require cessation of CL
wear [27, 28]. However, some combination of MPDSs with
some types of Si-HyCLs can lead to toxic staining of sufficient
severity to result in discontinuation of CL wear [28].
Currently, new products are being released to the market,
some of them with the claim of including active ingredients
to improve comfort. Other products include more complex
formulations to strength disinfection activity. This is neces-
sary to evaluate the effects on the comfort and physiological
status of the ocular surface. Therefore, the purpose of this
study was to evaluate and compare the clinical and subjective
performance, as well as the dehydration rates of a Si-Hy CL
in combination with three different MPDSs for sequential
periods of 1 month separated by 1 week without CLs.
2. Methods
This was a prospective, randomized, single-masked, cross-
over, single center, and comparative study. All procedures
conformed to the tenets of the Declaration of Helsinki. The
Ethics Committee of the School of Sciences of the University
of Minho (CEECUM) approved the study, and informed
consent was obtained from each individual prior to the
initiation of the study. Subjects must satisfy the following
inclusion and exclusion criteria (Table 1) to be eligible for the
study. To avoid differences related to the CL fit, the subjects
that could need to use toric or multifocal CLs were excluded.
Moreover, ageing is a risk factor to suffer dry eye and the use
of some medication, such as antihistamines or antidepres-
sants, may have influence over dryness symptoms.Therefore,
only healthy young subjects with myopic refraction and
astigmatism less than 1.0D were included in the study. The
age limitation was imposed to warrant uniformation and be
consistent with the most frequent age range of contact lens
wearers in most countries. In case the participants used to
use artificial tears or rewetting drops without preservatives
while they wore their habitual CLs, they were allowed to
use them but always in the same way. This means, if they
used to put a drop during the morning and another one
during the afternoon, they should do the same during the 3
months of follow-up period, the same rewetting drops, and
the same times per day with the three MPDSs.This will allow
us to evaluate the patients in the same conditions they were
used to andmeasure differences against baseline and between
MPDSs under the same conditions.
All subjects underwent a complete ocular examination to
ensure that each individual met all of the inclusion criteria
of the study. After recruitment, 31 subjects were included in
the study and they were asked to discontinue their CL wear
for 1 week before attending the baseline visit. In the baseline
visit, a new pair of CLs and a newMPDS were dispensed and
then, the subjects were scheduled for follow-up visits after 1
month of CL wear, being evaluated at 2 and 8 hours after lens
insertion. After the follow-up visits, subjects were instructed
to use their spectacles for 1 week and were then rescheduled
for dispensing a new MPDS and a new pair of CLs. This
procedure was repeated for eachMPDS, starting each subject
by one MPDS according to a predetermined randomization
schedule.
2.1. Contact Lens and MPDS Care Systems. All participants
were successfully refitted with Biofinity (Comfilcon A 48%
water content, Coopervision) Si-Hy CL and were instructed
to wear the CLs in daily wear basis. This is a Si-Hy CL that is
replaced monthly, the Si-Hy CLs are the most used nowadays
and the majority of the CLs fitted in the South of Europe,
the region where this study was performed, are replaced on
a monthly basis [4]. Beyond this, Biofinity represents a last
generation Si-Hy with high oxygen transmissibility and at the
same time mid water content and low modulus. We believe
that it is a good representative of the CL market.
The three MPDSs used in this study were Synergi
(Sauflon, UK), COMPLETE RevitaLens (Abbott Medical
Optics, Santa Ana, CA), and OPTI-FREE PureMoist (Alcon,
Fort Worth, TX). Table 2 shows the technical details of the
solutions involved in the comparison. Each solution was
used following the manufacturer’s instructions and the lens
case provided by the manufacturer of the MPDS, when
possible. All products were used with a rub-and-rinse step.
The subjects were not masked for lens care solutions but the
clinician was masked for the solution that each participant
was using during each month.
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Table 2: Composition of the MPDS used in the study.
OPTI-FREE
PureMoist
COMPLETE
RevitaLens Synergi
Manufacturer ALCON ABBOTT Sauflon
Disinfecting agent Polyquaternium-1 0.001%MAPD (ALDOX) 0.0006%
Polyquaternium-1 0.0003%
Alexidine 0.00016%
Oxipol
Oxychlorite complex (sodium chlorite
and hydrogen peroxide)
Buffer Boric acid; sorbitol
Boric acid, sodium borate
decahydrate, sodium chloride;
trisodium citrate dehydrate.
Phosphate
Chelating agent CitrateEDTA 0.05% EDTA Not known
Surfactant Poloxamine(Tetronic 1304) Tetronic 904 Poloxamer
Wetting agent HydraGlyde (EOBO-41;polyoxyethylene-poloxybutylene)
Hydroxypropyl methylcellulose (HPMC)
Polyvinylpyrrolidone (PVP)
Others Aminomethyl propanol (AMP-95) Antimicrobial case
2.2. Tests Performed. The participants graded their ocular
comfort experiences on a 1 to 10 Visual Analogue Scales
(VAS). Therefore, VAS were used to gauge comfort ratings
at baseline, with their habitual soft CLs, and then after 15
and 30 days using each MPDS. At the end of the study, the
participants had to show the preference by one of the three
MPDSs by forced choice. In this questionnaire, the partici-
pants had to say at what time they used to put and remove
their CLs, as well as at what time they started to feel the
CLs uncomfortable or felt dryness with the CLs, if these
symptoms took place. Moreover, they were asked about the
comfort and dryness with their CL with each MPDS. Their
satisfaction with the cleanliness and with CL clear vision was
also assessed. As there was not any programmed visit after 15
days using eachMPDS, the participants were asked to answer
the VAS questionnaire at home and to bring them at the 1-
month visit.
The ocular surface was examined with slit lamp biomi-
croscopy evaluating corneal staining, conjunctival staining,
and bulbar, limbal, and lid redness, aswell as tarsal roughness.
The scores were recorded according to the CCLRU grading
scales [29]. This scale has four images for each condition that
increase in severity from 1, which means “very slight,” to 4,
which means “severe.”
The tear quality was evaluated with noninvasive tear
break-up time (NIBUT) and with the tear break-up time
(BUT) tests. NIBUT was measured using the Medmont
topographer with and without CL. BUT was measured with
the slit lamp biomicroscopy after instilling sodium fluores-
cein (NaFL) with a prepared strip of NaFL. A yellow barrier
filter was used to enhance the contrast. Both tests were
assessed after asking the subjects to blink a couple times and
the measurements were performed three times to obtain a
more reliable value.
The CLs were weighed with a digital balance (model
AT210, Mettler Toledo, Giessen, Germany) at baseline, after
opening the blister of each CL, and at 1-month follow-up
visits, after 2 and 8 hours wearing the CL. At 1-month
visits, immediately after lens removal, the lens was placed in
a sterile holder and weighed. The analytical balance has a
scale capable of measuring within 0.001 g. An experienced
technician weighed the CL three times, after soaking the
CL, and removed the excess of liquid. The measurements
were performed always following the same procedure. Values
obtained were recorded and compared against the values
obtained before lens insertion for each given CL (baseline).
Dehydration rates were derived according to previously
described methodology by the equation: 𝑊𝑒𝑖𝑔ℎ𝑡 𝑙𝑜𝑠𝑠 =
[(𝑊𝑜𝑟𝑛 𝑙𝑒𝑛𝑠 𝑚𝑎𝑠𝑠 − 𝐵𝑎𝑠𝑒𝑙𝑖𝑛𝑒 𝑚𝑎𝑠𝑠)/𝐵𝑎𝑠𝑒𝑙𝑖𝑛𝑒 𝑚𝑎𝑠𝑠] × 100.
During the dispensing visits, the participants underwent
slit lamp examination, evaluation ofNIBUTwith andwithout
CL and BUT. These values were used as baseline values for
each MPDS.
2.3. Statistical Analysis. Statistical analysis was conducted
using SPSS v.19.0. Shapiro-Wilk test was used to evaluate
normal distribution of data. Analysis of variance (ANOVA
or Kruskal-Wallis test, depending on data distribution) with
Bonferroni post hoc correction was used to compare the
clinical and subjective outcomes of the threeMPDSs to check
for differences between solutions at a given visit or between
follow-up visits for a given MPDS. Mann-Whitney 𝑈 test
was used to evaluate differences among the MPDSs in lid
response at a given visit. Statistical significance was set at
the level of 𝛼 = 0.05. Sample size was estimated for an
80% statistical power to detect differences of 2 values in
comfort ratings, 4 seconds difference in NIBUT over the
lens or differences of 1.5% in dehydration rates considering a
statistical significance value of 0.05. To avoid the duplication
of the sample resulting from the interaction between both
eyes from the same patient, only the left eye from each patient
was used for statistical analysis.
3. Results
Of the 31 subjects enrolled, 25 were females (80.6%) and 6
were males (19.4%), with a mean age of 23 ± 4 years. Average
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Figure 1: Subjective perception of the subjects regarding comfort upon insertion (a), dryness during first hours of wear (b), end-of-day
comfort (c), and end-of-day dryness (d) with the three MPDSs at baseline, 15 days, and 1 month. Error bars represent standard error of mean
(SEM).
spherical equivalent refractionwas−2.75±1.30D for the right
eye and −2.91 ± 1.31D for the left eye.
There was only one discontinuation during the third
month of the study because one subject felt disappointed
after breaking 2 CLs with the case of Synergi solution. In this
regard, it is interesting to mention that 7 CLs were broken
during the study and 6 of themwere brokenwhile the subjects
were using the Synergi solution with its case. Of course, all
CLs were replaced and the appointments reprogramed to
make the visit after 1 month of CL use with each MPDS.
3.1. Subjective Questionnaire. The three MPDSs performed
similarly regarding the subjective perception of the subjects,
not finding statistically significant differences among the
three MPDSs for any question in the VAS questionnaire (𝑃 >
0.05, Kruskal-Wallis test).
The participants showed a consistent pattern of 12 to 13
hours/day of lens wear for 6 to 7 days/week. During this
period, they reported 11 to 11.5 hours of comfortable wear
over the month of lens wear. Differences between MPDSs
regarding total time or hours of comfortable lens wear were
not statistically significant.
Comfort at insertion changed from 8.5 with their habitual
CL to an average of 8.8 at 1-month visit. End-of-day comfort
also increasedwith the 3MPDSs from6.32with their habitual
CL to an average 7.4 at the end of the 1-month period. These
results are quite similar to the comfort reported previously
by other authors with Biofinity CL [30]. Figure 1 shows the
average values of comfort and dryness upon insertion and
at the end of the day. Differences between MPDSs for those
parameters were not statistically significant at any visit. In
the same respect, no statistically significant difference was
found for satisfaction neither with the cleanliness nor with
the clear vision. Forced choice preference recorded at the end
of the study was for Synergi in 26%, COMPLETE RevitaLens
in 37%, and OPTI-FREE PureMoist in 37%.
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Figure 2: Corneal staining type (a) and depth (b) and conjunctival staining (c) at baseline, 2-hour visit on day 30, and 8-hour visit on day 30.
Error bars represent standard error of mean (SEM).
3.2. Ocular Surface Signs. No statistically significant differ-
ences were observed among the three MPDSs in the slit
lamp observations at any visit, except for lid redness and
lid roughness. Palpebral conjunctiva showed a statistically
significantly different degree of redness between MPDSs on
day 30 at the 2-hour visit and a significantly different degree
of roughness at the 8-hour visit, as Table 3 shows. To evaluate
whichMPDSswere different fromeach other,Mann-Whitney
𝑈 tests were performed. For lid redness at the 2-hour visit,
statistically significant differences were seen, being the values
lower with COMPLETE RevitaLens than with the other two
MPDSs, not existing differences between Synergi and OPTI-
FREE PureMoist. Regarding lid roughness, Synergi showed
statistically significant higher scores than the other two
MPDSs, without observing differences between COMPLETE
RevitaLens and OPTI-FREE PureMoist.
Corneal staining increasedwith threeMPDSs, as Figure 2
shows. Statistically significant changes among visits were
found with COMPLETE RevitaLens and OPTI-FREE Pure-
Moist solutions (𝑃 < 0.05, Kruskal-Wallis test). After
analyzing the changes from visit to visit with the Bonferroni
test, it was seen that COMPLETE RevitaLens and OPTI-
FREE PureMoist increased statistically significantly from
baseline to day 30 after 2 hours of lens wear, while Synergi
solution increased statistically significantly from baseline to
day 30 after 8 hours of CLwear. Conjunctival staining showed
a statistically significant increase between each visit with the
3MPDSs (𝑃 < 0.05, Bonferroni test). These changes showed
an average increase in corneal staining from 0.4 to 0.8 and in
conjunctival staining from 0.5 to 1.7, being the staining scores
below 3, which is considered as “moderate staining” in the
CCLRU scales. SICS pattern was not observed in this study.
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Table 3: Values of lid redness and roughness with each MPDS in each visit, showing statistically significant differences in bold.
Baseline 2 hours on day 30 8 hours on day 30
Lid redness
Synergi 1.40 ± 0.37 1.62 ± 0.38 1.65 ± 0.47
COMPLETE RevitaLens 1.50 ± 0.43 1.42 ± 0.38 1.52 ± 0.43
OPTI-FREE PureMoist 1.49 ± 0.42 1.66 ± 0.37 1.58 ± 0.44
𝑃 0.756∗ 0.044∗ 0.545∗
Lid roughness whit light reflex
Synergi 1.17 ± 0.50 1.23 ± 0.55 1.45 ± 0.55
COMPLETE RevitaLens 1.03 ± 0.59 1.01 ± 0.56 1.07 ± 0.59
OPTI-FREE PureMoist 1.09 ± 0.67 1.04 ± 0.56 1.13 ± 0.58
𝑃 0.720∗ 0.238∗ 0.026∗
∗Kruskal-Wallis test.
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Figure 3: Bulbar redness (a) and limbal redness (b) with each MPDS at baseline, 2-hour visit on day 30, and 8-hour visit on day 30. Error
bars represent standard error of mean (SEM).
Bulbar redness showed statistically significant changes
with the three MPDSs (𝑃 < 0.05, Kruskal-Wallis), being
the increase statistically significant from baseline to 1-month
visit after 2 hours of lens wear for COMPLETE RevitaLens
and OPTI-FREE PureMoist (𝑃 < 0.05, Bonferroni test),
remaining stable for the rest of the day with COMPLETE
RevitaLens (𝑃 > 0.05, Bonferroni test). With Synergi and
OPTI-FREE PureMoist, a statistically significant increase was
seen from 2 to 8 hours of lens wear at 1-month visit (𝑃 <
0.05, Bonferroni test). Limbal redness showed a significant
increase between each visit with COMPLETE RevitaLens
and OPTI-FREE PureMoist (𝑃 < 0.05, Bonferroni test). In
general, bulbar redness showed an average change from 1.6
at baseline to 2.1 on day 30 after 8 hours wearing the CLs.
Limbal redness showed an average change from 1.5 at baseline
to 1.9 on day 30 after 8 hours wearing the CLs. None of
these parameters reached the level 3 considered as “moderate
redness” in the CCLRU scale, as it is shown in Figure 3.
3.3. Precorneal and Prelens Tear Film Parameters. Precorneal
tear film stability (BUT) showed a slight but non-statistically
significant decrease at 2-hour visit on day 30, but the values
recovered to baseline at 8-hour visit for the three MPDSs.
There were no statistically significant changes in NIBUTwith
CL, neither from the baseline to 1-month visits nor after 1
month from the 2 hours to the 8 hours with any MPDS.
However, NIBUT without CL changed between visits with
the three MPDSs. With Synergi solution, NIBUT without
CL was reduced at 2-hour visit on day 30 compared to
baseline but then, it returned to baseline values. With OPTI-
FREE PureMoist solution, a decrease was observed from 2
to 8 hours of visit on day 30. With regard to COMPLETE
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Figure 4: Prelens noninvasive tear break-up time (a), precorneal noninvasive tear break-up time (b), and break-up time without contact lens
(c) at baseline, 2-hour visit on day 30, and 8-hour visit on day 30. Error bars represent standard error of mean (SEM).
RevitaLens solution, a decrease was observed at 8-hour
visit on day 30 compared to baseline values. However, no
statistically significant differences among the three MPDSs
were observed in any visit. Figure 4 shows the changes in
these parameters with each MPDS. The differences observed
between NIBUT with CL and NIBUT without CL may be
related to the fact that the NIBUTwith CL is more dependent
on the lens material surface than the MPDS used, as it
has been suggested in a recent study performed also in the
CEORLab [31].
3.4. Contact Lens Dehydration. Dehydration rates at the 2-
hour visit were −2.6 ± 2.4%, −2.3 ± 2.7%, and −1.3 ±
0.9% for Synergi, COMPLETE RevitaLens, and OPTI-FREE
PureMoist, respectively (ANOVA, 𝑃 > 0.05). At the 8-hour
visit, these values increased to −4.3 ± 3.0%, −3.7 ± 2.8%, and
−2.7 ± 1.2%, respectively (ANOVA, 𝑃 > 0.05). COMPLETE
RevitaLens and OPTI-FREE PureMoist presented the lower
dehydration change from the 2 to 8 hours of visit on day 30
(−1.5 ± 1.1%).
4. Discussion
The three MPDSs performed similarly regarding the subjec-
tive perception of the subjects and the clinical signs observed
at the ocular surface.
SICS staining was not a frequent observation in this
clinical study. Despite that, a low-grade of asymptomatic
corneal punctate staining was found in most of the subjects
after 2 hours of CL wear and it did not disappear after 8
hours of CL use. Garofalo et al. in 2005 [27] found that toxic
corneal staining was most likely to be seen between 2 and
4 hours after CL inserting and then became more difficult
to be observed. Moreover, a recent study has reported that
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(a) (b)
(c)
Figure 5: Examples of different degrees of perilimbal conjunctival staining (indicated by the arrows) observed at the 8-hour visit with the
three MPDSs. From (a)–(c): from less to more intensive conjunctival staining.
36% of subjects showed some degree of SICS in a 1-month
study involving the random fitting of Air Optix or Proclear
with a hydrogen peroxide system when they were changed
to use a PHMB based MPDS and evaluated 2 hours after
lens insertion [32]. Instead of being a transient response, the
maintenance of the corneal staining during the day suggests
that other factors different from the lens solution itself might
be related to the “very slight” staining pattern found in
the present study. In this regard, it is important to bear in
mind that corneal staining may be due to many different
conditions related to CL characteristics or to CL wearer
conditions [33]. Corneal staining found is on average very
low, either for staining type or depth. However, COMPLETE
RevitaLens and OPTI-FREE PureMoist showed quite similar
staining patterns, being higher than Synergi. This fact may
be related to the interaction between the CL and the solution
components, but it is not possible to confirm the cause only
with the data of the manufacturers.
Contrary to the corneal staining, conjunctival staining
increased significantly with all MPDSs. A previous study
showed a significant increase in conjunctival staining in CL
wearers compared to no CL wearers [34]. The most common
type of conjunctival staining found was a perilimbal staining,
as shown in Figure 5. This result may reflect an ocular
response potentially related to CL dehydration ormechanical
interaction of the CL with the ocular surface. According to
previous studies, conjunctival staining could be related to the
lens geometry, especially with the edge lens profile, and the
material rigidity [30, 35]. In the present study, all subjects
used always the same Si-Hy CL, which suggests that the
conjunctival stainingmay bemore related to theCL itself than
with the MPDSs used.
The pattern of slight increase in bulbar and limbal redness
seems also related to the presence of the CL rather than the
MPDS, as a similar pattern was found with the three lens
care systems.The changes observed are consistent with those
previously reported by other authors [36].
Despite some disputes existing in the literature, several
studies have shown similarity in the performance of different
MPDS despite pointing to different trends. For instance,
some studies have found no differences in comfort [31,
37–40] while others find similar corneal and conjunctival
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staining [38, 40–43] among different lens care solutions.
However, there are also studies that have found differences
in comfort [11, 41, 44], corneal staining [11, 25, 44–47], and
even in the amount of lens deposits [11, 44, 46]. Table 4
summarizes the main clinical and subjective preference
outcomes of different studies comparing the performance of
different MPDSs over the past 12 years. Many of these studies
focus their attention on comfort and corneal staining. In the
present study, the ocular response to three MPDSs that are
approved for being used with Si-Hy CLs is shown, evaluating
not only the corneal and conjunctival staining but also the
bulbar and limbal redness and the tarsal response. The three
MPDSs are relatively new in the market and all of them
include components to enhance the comfort, surfactants, and
wetting agents. In this regard, the comfort with these MPDSs
in combination with a Si-Hy CL that is replaced monthly was
assed.
Taking into account that lid redness after 2 hours and
roughness after 8 hours of CL wear, which could be con-
sidered as short and medium term, showed statistically sig-
nificant differences among the three MPDSs, tarsal response
should be also considered in the context of evaluation of the
clinical performance of MPDSs at the ocular surface. The
tarsal conjunctival tissue is widely recognized for responding
to immunological insult. Considering the complex compo-
sition of current MPDSs, such response can be used as a
relevant biomarker in the evaluation of the clinical perfor-
mance of modern MPDSs. Contrary to corneal staining and
conjunctival staining, or even bulbar redness, lid response
has not been evaluated frequently when assessing the ocular
response to care solutions [26, 27, 48]. Despite the fact
that no significant increase in lid redness or lid roughness
was seen with the use of any of the three MPDSs, the lid
redness at 2-hour visit and the lid roughness with light reflex
at 8-hour visit were statistically significantly. Lid redness
was lower with the COMPLETE RevitaLens compared to
the other two MPDSs and lid roughness was higher with
Synergi compared to the other two MPDSs. This fact may
be related to the solution delivery among the day being
the lid redness a short response and the lid roughness a
more retarded response. In fact, other authors have seen
that the lid roughness is reduced with the peroxide use,
CL solution without preservatives [49, 50]. Moreover, the
components used to keep the surface of the CLs smoother
may have some effect on the lid response.Hence, the scientific
community should paymore attention to this immunological
active location at the ocular surface as it might be a very
selective target for some ingredients of the CL care sys-
tems.
This study has, however, some important limitations.
One of them is that the participants only were evaluated
after 1 month using each MPDS. It could be possible that
more ocular surface responses take place during the first
days after changing the solution. Moreover, the fact that the
subjects were not masked about theMPDSmay influence the
subjective response that was not taken into account.
In summary, the three MPDSs performed similarly re-
garding the subjective perception of the subjects and the clin-
ical signs observed at the ocular surface. Tarsal conjunctival
response should be also considered in the context of the
clinical performance of MPDSs at the ocular surface.
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